Lee Young Ik, Lee Hak Min, Jo Jung Ki, Lee Sangchul, Hong Sung Kyu, Byun Seok-Soo, Lee Sang Eun, Oh Jong Jin
Department of Urology, Seoul National University Bundang Hospital, Seongnam, Korea.
PLoS One. 2016 Feb 5;11(2):e0148690. doi: 10.1371/journal.pone.0148690. eCollection 2016.
Our hypothesis is that the location of the seminal vesicles near the base of the prostate, the more positive cores are detected in the base, the greater the risk of seminal vesicle invasion. Therefore we investigate the clinical outcomes of base dominant prostate cancer (BDPC) in transrectal ultrasound (TRUS) -guided biopsies compared with anteromiddle dominant prostate cancer (AMPC).
From November 2003 to June 2014, a total of 990 intermediate and high risk prostate cancer (PCa) patients who underwent radical prostatectomy (RP) were enrolled and stratified into two groups according to proportion of positive cores-BDPC group had ≥ 33.3% ratio of positive cores from the prostate base among all positive cores and AMPC group < 33.3% in systemic biopsy. Between two groups, we compared the rate of pathologic outcomes and biochemical recurrence (BCR). We performed multivariate logistic regression model to confirm the significance of BDPC to seminal vesicle invasion (SVI) and Cox proportional hazard analysis to BCR.
Among these 990 PCa patients, the 487 patients in BDPC group had more advanced clinical stage (p<0.001), a higher biopsy GS (p = 0.002), and a higher rate of extracapsular extension (ECE), SVI and BCR (all p<0.001) than AMPC group. The patients in BDPC group had poor BCR free survival rate via Kaplan-meier analysis (p<0.001). The ratio of the base positive cores was a significant predictor to SVI in multivariate analysis (p < 0.001) and significant predictor of BCR in multivariate Cox proportional analysis (hazard ratio: 1.466, p = 0.004).
BDPC in TRUS-guided prostate biopsies was significantly associated with SVI and BCR after adjusting for other clinical factors. Therefore, BDPC should be considered to be a more aggressive tumor despite an otherwise similar cancer profile.
我们的假设是,精囊位于前列腺底部附近,在前列腺底部检测到的阳性核心越多,精囊受侵风险越大。因此,我们研究了经直肠超声(TRUS)引导活检中以底部为主的前列腺癌(BDPC)与以前中部为主的前列腺癌(AMPC)的临床结局。
2003年11月至2014年6月,共有990例接受根治性前列腺切除术(RP)的中高危前列腺癌(PCa)患者入组,并根据阳性核心比例分为两组——BDPC组所有阳性核心中来自前列腺底部的阳性核心比例≥33.3%,AMPC组在系统活检中该比例<33.3%。我们比较了两组之间的病理结局和生化复发(BCR)率。我们进行了多因素逻辑回归模型以确认BDPC对精囊侵犯(SVI)的意义,并对BCR进行Cox比例风险分析。
在这990例PCa患者中,BDPC组的487例患者临床分期更晚(p<0.001),活检 Gleason评分更高(p = 0.002),包膜外侵犯(ECE)、SVI和BCR发生率更高(均p<0.001)。通过Kaplan-meier分析,BDPC组患者的无BCR生存率较差(p<0.001)。在多因素分析中,底部阳性核心比例是SVI的显著预测指标(p < 0.001),在多因素Cox比例分析中是BCR的显著预测指标(风险比:1.466,p = 0.004)。
在调整其他临床因素后,TRUS引导的前列腺活检中的BDPC与SVI和BCR显著相关。因此,尽管BDPC在其他方面的癌症特征相似,但应被视为更具侵袭性的肿瘤。